Plancorp LLC’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $453K | Sell |
89,500
-176
| -0.2% | -$891 | 0.02% | 238 |
|
|
2025
Q1 | $474K | Buy |
89,676
+2,092
| +2% | +$11.1K | 0.02% | 215 |
|
|
2024
Q4 | $592K | Buy |
87,584
+10,000
| +13% | +$67.6K | 0.02% | 171 |
|
|
2024
Q3 | $511K | Buy |
77,584
+6,974
| +10% | +$46K | 0.02% | 191 |
|
|
2024
Q2 | $530K | Buy |
70,610
+43,000
| +156% | +$323K | 0.02% | 174 |
|
|
2024
Q1 | $275K | Buy |
27,610
+17,000
| +160% | +$169K | 0.01% | 244 |
|
|
2023
Q4 | $105K | Sell |
10,610
-90
| -0.8% | -$887 | 0.01% | 275 |
|
|
2023
Q3 | $81.9K | Buy |
+10,700
| New | +$81.9K | ﹤0.01% | 256 |
|